Home > Income Statement > KILITCH DRUGS (INDIA)

KILITCH DRUGS (INDIA)
Consolidated Net Profit

    Back to Income Statement
KILITCH DRUGS (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for KILITCH DRUGS (INDIA)
Please provide your vote to see the results

KILITCH DRUGS (INDIA) Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹27 Cr₹15 Cr₹10 Cr₹7.37 Cr₹3.67 Cr

What is the latest Consolidated Net Profit of KILITCH DRUGS (INDIA) ?

The latest Consolidated Net Profit ratio of KILITCH DRUGS (INDIA) is ₹27 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹27 Cr
Mar2024₹15 Cr
Mar2023₹10 Cr
Mar2022₹7.37 Cr
Mar2021₹3.67 Cr

How is Consolidated Net Profit of KILITCH DRUGS (INDIA) Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹27 Cr
82.87
Mar2024 ₹15 Cr
39.75
Mar2023 ₹10 Cr
41.82
Mar2022 ₹7.37 Cr
100.68
Mar2021 ₹3.67 Cr -

Compare Consolidated Net Profit of peers of KILITCH DRUGS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA) ₹546.9 Cr -4.8% -11.1% -6.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹393,323.0 Cr 1.7% -5.7% -7.4% Stock Analytics
DIVIS LABORATORIES ₹160,825.0 Cr 0.8% -6.7% 3.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,349.0 Cr 0.6% 4.3% 24.4% Stock Analytics
CIPLA ₹106,048.0 Cr -4.7% -12.3% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹103,494.0 Cr 6.3% -2.1% -4.1% Stock Analytics


KILITCH DRUGS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA)

-4.8%

-11.1%

-6.9%

SENSEX

-1.7%

-4.3%

6.2%


You may also like the below Video Courses